Whole Blood Serotonin Levels and Platelet 5-HT_2A Binding in Autism Spectrum Disorder

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Elevated whole blood serotonin (WB5-HT) is a consistent biomarker in autism spectrum disorder (ASD).
• Previous research suggests reduced platelet serotonin 5-HT2A receptor binding in individuals with ASD.
• Understanding the serotonin system's role in ASD is crucial for developing targeted interventions.

Purpose of the Study:

• To investigate the relationship between whole blood serotonin (WB5-HT) levels and platelet serotonin 5-HT2A specific binding in individuals with ASD.
• To determine if the association between WB5-HT and platelet 5-HT2A binding differs between individuals with ASD and neurotypical controls.
• To explore potential alterations in platelet serotonin system regulation in ASD.

Main Methods:

• Quantified whole blood serotonin (WB5-HT) levels and platelet 5-HT2A specific binding in 110 individuals with ASD and 18 controls.
• Employed multiple regression analyses to examine the predictive relationship between WB5-HT and platelet 5-HT2A binding.
• Compared WB5-HT levels and platelet 5-HT2A binding between the ASD and control groups.

Main Results:

• Individuals with ASD exhibited significantly higher WB5-HT levels compared to controls.
• No significant difference was observed in platelet 5-HT2A specific binding between the ASD and control groups.
• Platelet 5-HT2A binding predicted WB5-HT in controls, but this relationship was not significant in the ASD sample.

Conclusions:

• The findings suggest that the regulatory relationship between WB5-HT and platelet 5-HT2A binding is altered in autism spectrum disorder.
• These results point towards distinct mechanisms of serotonin system regulation in individuals with ASD.
• Further research is warranted to elucidate the specific neurobiological underpinnings of these observed differences in ASD.